👉 Let us know in the comments: Are you planning to list your IVD in Hong Kong under MDACS, or are you comparing it with other Asian regulatory pathways?
Unlike Mainland China’s NMPA (formerly CFDA) risk-based classification (Class I to III), Hong Kong currently operates under the – a voluntary but widely adopted framework. hong kong ivd classification
🔬